Informações de Integra Lifesciences Holdings Corp

Mais detalhes de Integra Lifesciences Holdings Corp Empresa

Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.



Código da empresaIART

Nome da EmpresaIntegra Lifesciences Holdings Corp

Data de listagemAug 16, 1995

CEOMs. Mojdeh Poul

Número de funcionários4396

Tipo de títulosOrdinary Share

Fim do ano fiscalAug 16

Endereço1100 Campus Road

CidadePRINCETON

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal08540

Telefone16092750500

Sitehttps://www.integralife.com/

Código da empresaIART

Data de listagemAug 16, 1995

CEOMs. Mojdeh Poul

Executivos da empresa Integra Lifesciences Holdings Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.59M

-11.20%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

Mr. Harvinder Singh

Executive Vice President, President - International Business

21.94K

+65.53%

Ms. Mojdeh Poul

President, Chief Executive Officer, Director

--

Ms. Shaundra D. Clay

Independent Director

--

Mr. Chris Ward

IR Contact Officer

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.59M

-11.20%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Neurosurgery

208.99M

50.29%

Wound Reconstruction and Care

84.75M

20.39%

Private Label

26.90M

6.47%

Por RegiãoUSD

Nome

Receita

Proporção

United States

306.31M

73.70%

Asia Pacific

47.73M

11.48%

Europe

42.59M

10.25%

Rest of World

18.97M

4.56%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Neurosurgery

208.99M

50.29%

Wound Reconstruction and Care

84.75M

20.39%

Private Label

26.90M

6.47%

Distribuição de ações

Atualizado em: qua, 8 de out

Investidores

Tipos de investidores

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

12.11%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.63%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.00%

Outro

52.88%

Investidores

Proporção

BlackRock Institutional Trust Company, N.A.

12.11%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.63%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.00%

Outro

52.88%

Tipos de investidores

Investidores

Proporção

Investment Advisor

36.06%

Investment Advisor/Hedge Fund

35.42%

Hedge Fund

18.02%

Corporation

10.93%

Research Firm

3.22%

Individual Investor

3.19%

Pension Fund

1.25%

Bank and Trust

0.44%

Sovereign Wealth Fund

0.04%

Participação acionária institucional



Atualizado em: dom, 5 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

579

73.60M

94.48%

-24.35M

2025Q2

600

89.38M

114.72%

-18.72M

2025Q1

635

87.01M

111.97%

-18.30M

2024Q4

636

81.93M

106.10%

-20.27M

2024Q3

638

82.93M

106.93%

-12.58M

2024Q2

628

84.82M

107.92%

-1.75M

2024Q1

613

79.36M

101.18%

-3.69M

2023Q4

597

79.81M

101.26%

-5.74M

2023Q3

592

81.88M

100.31%

-3.94M

2023Q2

587

82.30M

100.29%

-6.57M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

BlackRock Institutional Trust Company, N.A.

9.43M

12.11%

-322.52K

-3.31%

Jun 30, 2025

TRU ST Partnership, L.P.

8.52M

10.93%

--

Feb 28, 2025

The Vanguard Group, Inc.

7.50M

9.63%

+34.14K

+0.46%

Jun 30, 2025

Rubric Capital Management LP

7.35M

9.44%

+2.71M

+58.36%

Jun 30, 2025

Fuller & Thaler Asset Management Inc.

3.89M

5%

-29.99K

-0.76%

Jun 30, 2025

Invesco Advisers, Inc.

3.18M

4.08%

+51.84K

+1.66%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.92M

3.74%

+333.71K

+12.91%

Jun 30, 2025

State Street Investment Management (US)

2.83M

3.63%

+79.03K

+2.88%

Jun 30, 2025

Boston Management and Research

2.74M

3.52%

--

Jun 30, 2025

Paradigm Capital Management, Inc.

2.18M

2.8%

+796.30K

+57.49%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: dom, 2 de nov

Nome

Proporção

iShares Neuroscience and Healthcare ETF

1.68%

SPDR S&P Health Care Equipment ETF

1.53%

ROBO Global Healthcare Technology & Innovation ETF

1.15%

Invesco S&P SmallCap Health Care ETF

0.61%

Invesco NASDAQ Future Gen 200 ETF

0.46%

First Trust Small Cap Value AlphaDEX Fund

0.39%

Inspire Small/Mid Cap ESG ETF

0.22%

First Trust Small Cap Core Alphadex Fund

0.2%

Royce Quant Small-Cap Quality Value ETF

0.17%

iShares S&P Small-Cap 600 Value ETF

0.13%

Ver Mais

iShares Neuroscience and Healthcare ETF

Proporção1.68%

SPDR S&P Health Care Equipment ETF

Proporção1.53%

ROBO Global Healthcare Technology & Innovation ETF

Proporção1.15%

Invesco S&P SmallCap Health Care ETF

Proporção0.61%

Invesco NASDAQ Future Gen 200 ETF

Proporção0.46%

First Trust Small Cap Value AlphaDEX Fund

Proporção0.39%

Inspire Small/Mid Cap ESG ETF

Proporção0.22%

First Trust Small Cap Core Alphadex Fund

Proporção0.2%

Royce Quant Small-Cap Quality Value ETF

Proporção0.17%

iShares S&P Small-Cap 600 Value ETF

Proporção0.13%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados